Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett-Mayer

Showing results (41-50 of 289) with videos related to

Pageof 29
Sort By:
Clinical Trials (London, England)|April 4, 2024
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project OptimusPeter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, et al.
Journal of Community Health|December 13, 2007
The relationship of body size to participation and success in a fruits and vegetables intervention among low-income womenAnn C Klassen, Elizabeth Garrett-Mayer, Peter S Houts, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2009
Repeatable battery for assessment of neuropsychological status in early Parkinson's diseaseChengwu Yang, Elizabeth Garrett-Mayer, Jay S Schneider, et al.
Plos One|September 10, 2014
Regulation of the tumor suppressor FOXO3 by the thromboxane-A2 receptors in urothelial cancerPhilip M Sobolesky, Perry V Halushka, Elizabeth Garrett-Mayer, et al.
JCO Clinical Cancer Informatics|June 1, 2024
Characterizing the Increase in Artificial Intelligence Content Detection in Oncology Scientific Abstracts From 2021 to 2023Frederick M Howard, Anran Li, Mark F Riffon, et al.
JAMA Network Open|April 6, 2019
Attributable Failure of First-line Cancer Treatment and Incremental Costs Associated With Smoking by Patients With CancerGraham W Warren, Kathleen B Cartmell, Elizabeth Garrett-Mayer, et al.
The American Journal of Clinical Nutrition|July 5, 2012
Vitamin D3 supplementation (4000 IU/d for 1 y) eliminates differences in circulating 25-hydroxyvitamin D between African American and white menElizabeth Garrett-Mayer, Carol L Wagner, Bruce W Hollis, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 6, 2011
Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokersKatherine K Ryan, Elizabeth Garrett-Mayer, Anthony J Alberg, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 16, 2009
Adolescent nondaily smokers: favorable views of tobacco yet receptive to cessationMatthew J Carpenter, Elizabeth Garrett-Mayer, Camelia Vitoc, et al.
NPJ Precision Oncology|July 3, 2025
Prevalence of targetable genomic alterations among a diverse population participating in the ASCO TAPUR StudyPam K Mangat, M Kelsey Kirkwood, Dominique C Hinshaw, et al.
Pageof 29

Showing results (41-50 of 289) with videos related to

Sort By:
Pageof 29
Clinical Trials (London, England)|April 4, 2024
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project OptimusPeter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, et al.
Journal of Community Health|December 13, 2007
The relationship of body size to participation and success in a fruits and vegetables intervention among low-income womenAnn C Klassen, Elizabeth Garrett-Mayer, Peter S Houts, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2009
Repeatable battery for assessment of neuropsychological status in early Parkinson's diseaseChengwu Yang, Elizabeth Garrett-Mayer, Jay S Schneider, et al.
Plos One|September 10, 2014
Regulation of the tumor suppressor FOXO3 by the thromboxane-A2 receptors in urothelial cancerPhilip M Sobolesky, Perry V Halushka, Elizabeth Garrett-Mayer, et al.
JCO Clinical Cancer Informatics|June 1, 2024
Characterizing the Increase in Artificial Intelligence Content Detection in Oncology Scientific Abstracts From 2021 to 2023Frederick M Howard, Anran Li, Mark F Riffon, et al.
JAMA Network Open|April 6, 2019
Attributable Failure of First-line Cancer Treatment and Incremental Costs Associated With Smoking by Patients With CancerGraham W Warren, Kathleen B Cartmell, Elizabeth Garrett-Mayer, et al.
The American Journal of Clinical Nutrition|July 5, 2012
Vitamin D3 supplementation (4000 IU/d for 1 y) eliminates differences in circulating 25-hydroxyvitamin D between African American and white menElizabeth Garrett-Mayer, Carol L Wagner, Bruce W Hollis, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 6, 2011
Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokersKatherine K Ryan, Elizabeth Garrett-Mayer, Anthony J Alberg, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 16, 2009
Adolescent nondaily smokers: favorable views of tobacco yet receptive to cessationMatthew J Carpenter, Elizabeth Garrett-Mayer, Camelia Vitoc, et al.
NPJ Precision Oncology|July 3, 2025
Prevalence of targetable genomic alterations among a diverse population participating in the ASCO TAPUR StudyPam K Mangat, M Kelsey Kirkwood, Dominique C Hinshaw, et al.
Pageof 29